share_log

The Oncology Institute Partners With House Rx to Accelerate Growth of Pharmacy Operations

The Oncology Institute Partners With House Rx to Accelerate Growth of Pharmacy Operations

腫瘤學研究所與House Rx合作,加速藥房業務的增長
GlobeNewswire ·  2023/07/31 08:00

Collaborative efforts aimed at expanding TOI's current specialty medication services

旨在擴大 TOI 當前的特種藥物服務的合作努力

SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI) and House Rx announced today that they have entered into a multi-year relationship that will integrate House Rx's specialty medication dispensing model to operate and manage TOI's clinic and pharmacy locations in multiple markets.

舊金山,2023 年 7 月 31 日(GLOBE NEWSWIRE)— 腫瘤學研究所 納斯達克股票代碼:TOI)和House Rx今天宣佈,他們已經建立了爲期多年的合作關係,該合作關係將整合House Rx的特種藥物配送模式,以運營和管理TOI在多個市場的診所和藥房。

House Rx provides clinics with specialized technology and services support from pharmacists and care coordinators. House Rx staff are integrated with the clinic to help patients start therapy as quickly as possible and drive adherence to treatment for better outcomes.

House Rx爲診所提供藥劑師和護理協調員提供的專業技術和服務支持。House Rx的工作人員與診所整合,以幫助患者儘快開始治療,並提高對治療的依從性,以獲得更好的療效。

TOI's alignment with House Rx will expand patient access to oral specialty medications via TOI dispensary and pharmacy locations, and enhance in-office dispensary operations. The relationship will further enable TOI to provide convenient and affordable access to value-based therapies for patients as part of its comprehensive community-based care model.

TOI與House Rx的合作將擴大患者通過TOI藥房和藥房獲得口服特種藥物的機會,並加強辦公室內藥房的運營。作爲其全面的社區護理模式的一部分,這種關係將進一步使TOI能夠爲患者提供便捷且負擔得起的基於價值的療法。

"By partnering with House Rx, we will accelerate the growth of our clinic-based oral drug dispensing capabilities and improve our ability to add pharmacy locations in California and Texas that will allow us to access patient populations that we previously could not serve," said Dr. Daniel Virnich, CEO of The Oncology Institute. "We see this as one of the key drivers of our growth in upcoming years."

腫瘤學研究所首席執行官丹尼爾·維爾尼奇博士說:“通過與House Rx合作,我們將加快我們在臨床口服藥物配送能力的增長,提高我們在加利福尼亞和德克薩斯州增加藥房地點的能力,這將使我們能夠接觸以前無法服務的患者羣體。”“我們認爲這是我們未來幾年增長的關鍵驅動力之一。”

"With TOI, we have an innovative partner that cares deeply about delivering value-based care in the community setting," said Tesh Khullar, President and Co-Founder of House Rx. "By adopting our dispensing services and technology, TOI will strengthen their value-based care offering by ensuring more patients can access their specialty medications and receive the best possible outcomes from their treatments."

House Rx總裁兼聯合創始人Tesh Khullar說:“有了TOI,我們就有了創新的合作伙伴,他們非常關心在社區環境中提供基於價值的護理。”“通過採用我們的配藥服務和技術,TOI將確保更多的患者能夠獲得特種藥物並從治療中獲得儘可能好的結果,從而加強他們基於價值的護理服務。”

About The Oncology Institute, Inc.
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 100+ employed clinicians and more than 800 teammates in over 65 clinic locations and growing, TOI is changing oncology for the better. For more information visit .

關於腫瘤研究所有限公司
TOI 成立於 2007 年,通過在社區環境中提供高度專業化、基於價值的癌症護理,推動腫瘤學發展。TOI 爲大約 180 萬患者提供尖端的循證癌症護理,包括臨床試驗、輸血和其他傳統上與最先進的護理提供組織相關的護理提供模式。TOI 在 65 個診所擁有超過 100 名受僱的臨床醫生和 800 多名隊友,而且還在不斷壯大,正在使腫瘤學變得更好。欲了解更多信息,請訪問 。

About House Rx
House Rx is a healthcare technology and services company focused on making specialty medication more accessible and affordable. The company partners with specialty clinics across the country to enable community-based clinics to offer medically integrated dispensing, ultimately bringing together medical and pharmacy expertise to better serve patients, lower the cost of care, and create a better experience for patients and their caregivers. Learn more at .

關於 House Rx
House Rx是一家醫療技術和服務公司,專注於使特殊藥物更容易獲得和負擔得起。該公司與全國各地的專科診所合作,使社區診所能夠提供醫療綜合配藥,最終彙集醫療和藥學專業知識,更好地爲患者提供服務,降低護理成本,爲患者及其護理人員創造更好的體驗。要了解更多信息,請訪問 。

Investors

投資者

Solebury Strategic Communications
investors@theoncologyinstitute.com

索爾伯裏戰略傳播
investors@theoncologyinstitute.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論